{"version":"1.0","type":"link","title":"Cost-effectiveness of perioperative nivolumab + neoadjuvant platinum doublet chemotherapy as treatment for resectable non-small cell lung cancer in the United States.","author_name":"White B 외","author_url":"https://prs-insight.online/author/White%20B","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/101489","thumbnail_width":1200,"thumbnail_height":630}